DNA Methlyation Society's Main Objective: Fostering Communication Among Scientists

Author: Stanley Hattman As scientific progress and information has exploded in all areas of biomedical research, there has been a concomitant proliferation of journals. Keeping abreast of the published literature in all disciplines, as well as communication of other useful forms of information, has been made more difficult by this proliferation. To some measure, professional societies could be more active in promoting communication among their own members, as well as to the greater scientific

Written byStanley Hattman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Author: Stanley Hattman

As scientific progress and information has exploded in all areas of biomedical research, there has been a concomitant proliferation of journals. Keeping abreast of the published literature in all disciplines, as well as communication of other useful forms of information, has been made more difficult by this proliferation. To some measure, professional societies could be more active in promoting communication among their own members, as well as to the greater scientific community.

This is one important objective of the DNA Methylation Society, which was founded last year, with Melanie Ehrlich, a professor of biochemistry at Tulane University, as its first president.

It is almost a half-century since the discovery of modified bases in DNA in 1948 and "host-induced modification" in 1952. Initially, host-induced modification referred to a change in bacteriophage host range resulting from a single cycle of growth in a given strain of bacteria. Loss of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies